Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
- 15 March 2002
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (6) , 1668-1676
- https://doi.org/10.1200/jco.20.6.1668
Abstract
PURPOSE: Preclinical studies have shown good anticancer activity following targeting of a polymer bearing doxorubicin with galactosamine (PK2) to the liver. The present phase I study was devised to...Keywords
This publication has 0 references indexed in Scilit: